IBD and infliximab: Is this the end of proactive therapeutic drug monitoring?
Type de matériel :
TexteLangue : français Détails de publication : 2022.
Ressources en ligne : Abrégé : Syversen SW, Jørgensen KK, Goll GL, et al. Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients with Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial. JAMA 2021; 325 (17): 1744–54
Nous n'avons pas d'exemplaire de ce document
78
Syversen SW, Jørgensen KK, Goll GL, et al. Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients with Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial. JAMA 2021; 325 (17): 1744–54
Réseaux sociaux